MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
OPKO Health DSO Ratio 2011-2026 | OPK
Annual DSO Ratio OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 240 | 252 | 70.3 | 56.1 | 53.5 | 63.8 | 59.7 | 64 | 74.5 | 155 | 92.3 | 119 | 183 | 164 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 252 | 53.5 | 118 |
Quarterly DSO Ratio OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.9 | 61.7 | 55.7 | 54.3 | 60.1 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 417 | 324 | 71.4 | 92.2 | 77.4 | 81.4 | 87.2 | 87.4 | 75.7 | 59.5 | 119 | 164 | 189 | 175 | 198 | 168 | 136 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 417 | 31.3 | 89.2 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
63.8 | $ 120.47 | 1.2 % | $ 36.6 B |  USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.9 | 2.47 % | $ 94.1 K | USA |
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 22.13 | -5.98 % | $ 243 M |  China |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
49.2 | $ 27.97 | 1.43 % | $ 777 M | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 14.17 | 2.72 % | $ 428 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 179.12 | 1.95 % | $ 8.88 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
IDEXX Laboratories
IDXX
|
43.5 | $ 638.42 | 0.62 % | $ 51.3 B | USA |
 |
Illumina
ILMN
|
61.3 | $ 131.73 | 1.67 % | $ 20.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 282.44 | -0.19 % | $ 23.5 B | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 79.34 | 0.63 % | $ 5.35 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
41.7 | $ 15.04 | -2.97 % | $ 1.95 B | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 319.33 | 0.2 % | $ 27.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
52.3 | $ 5.43 | 2.65 % | $ 503 M | USA |
 |
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 9.65 | 1.1 % | $ 1.24 B | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.12 | - | $ 1.42 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 209.29 | 0.44 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
55.3 | $ 204.98 | 0.48 % | $ 146 B | USA |
 |
National Research Corporation
NRC
|
33 | $ 13.39 | - | $ 329 M | USA |
 |
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | $ 103.46 | 0.09 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
92.3 | $ 8.57 | -1.95 % | $ 537 M | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 10.5 | 1.94 % | $ 298 M | Israel |
 |
DexCom
DXCM
|
87 | $ 71.55 | -2.09 % | $ 27.9 B | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
71.8 | $ 1.62 | 6.25 % | $ 486 M | USA |
 |
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 111.03 | 2.14 % | $ 9.16 B |  Irlanda |
 |
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Precipio
PRPO
|
28.1 | $ 25.4 | 1.7 % | $ 33 M | USA |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
51.5 | $ 19.2 | 2.13 % | $ 1.02 B | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |